When: Friday, Aug. 22 from 3 p.m. to 10 p.m. and Saturday, Aug. 23 and Sunday, Aug. 24 from 1 p.m. to 10 p.m. Where: Portland ...

Viking Therapeutics said Tuesday its experimental weight-loss pill helped patients lose 12.2% of their body weight in a ...

Viking's key drug demonstrated excellent body weight reduction data in a phase 2 trial, but its safety and tolerability data ...

The company is the latest facing historic losses as pharmaceutical firms compete to develop a weight-loss pill.

Viking Therapeutics (VKTX 5.71%) fell a whopping 39.2% from their previous close on Tuesday, Aug. 19. Investors were reacting ...

The oral formulation led to up to 12.2% weight loss over three months, a weaker outcome versus late-stage treatments from Eli ...

An archaeologist in Sweden spent three years traveling in vessels built like those from 1,000 years ago. He discovered lost ...

Viking Therapeutics Inc. plunged in early trading on Tuesday after its experimental obesity pill disappointed in a mid-stage ...

Viking Therapeutics Inc.’s worst stock drop in nine years has handed traders betting against the company a gain big enough to ...

Viking Therapeutics reported a large number of patients dropped out of a study of its experimental weight-loss pill.

As the late summer sun beat down on a national park in Norway, archaeologists trekked across the glacial landscape, scouring ...

From the savage street battles of Rostov to the frozen mountain passes of the Caucasus, the SS Viking Division was pushed to ...